1986
DOI: 10.1001/jama.255.10.1299
|View full text |Cite
|
Sign up to set email alerts
|

Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
35
0
2

Year Published

1989
1989
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 52 publications
(39 citation statements)
references
References 0 publications
2
35
0
2
Order By: Relevance
“…In the study by Vandenbroucke et al (6). a large nonresponse rate (40%) may have led to bias, irrespective of whether response rates were identical or different in patient and control groups.…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…In the study by Vandenbroucke et al (6). a large nonresponse rate (40%) may have led to bias, irrespective of whether response rates were identical or different in patient and control groups.…”
Section: Discussionmentioning
confidence: 95%
“…both groups conducted new case-control studies. In 1985, the Mayo Clinic group again reported finding no protective effect attributable to the use of oral contraceptives (3, and in 1986, Vandenbroucke et a1 (6) again noted a protective effect of oral contraceptives; in addition, they reported a two-thirds reduction in the incidence of RA among users of any noncontraceptive hormone.…”
mentioning
confidence: 99%
“…No definite conclusion could be drawn, since a beneficial effect has been documented in some older studies [80][81][82] while in others the pills had no effect [83,84]. This may reflect the reduced amount of estrogen in the pills and the use of synthetically modified estrogen (further discussed in the section on estrogen receptors).…”
Section: Sex Hormonesmentioning
confidence: 98%
“…Thus, well-controlled epidemiological case-control studies have shown that administration of estrogenes, either as contraceptives or as postmenopausal replacement therapy, reduce the risk of acquiring RA [90]. This is an interesting contrast to the situation in systemic lupus erythematosus, where administration of estrogens often appear to enhance the disease process.…”
Section: Response To Immunoregulation and Therapymentioning
confidence: 99%